These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10702712)

  • 21. Latency and reactivation of human cytomegalovirus.
    Sissons JG; Bain M; Wills MR
    J Infect; 2002 Feb; 44(2):73-7. PubMed ID: 12076064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activator protein-1 transactivation of the major immediate early locus is a determinant of cytomegalovirus reactivation from latency.
    Krishna BA; Wass AB; O'Connor CM
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20860-20867. PubMed ID: 32788362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny.
    O'Connor CM; Murphy EA
    J Virol; 2012 Sep; 86(18):9854-65. PubMed ID: 22761372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models.
    Lemmermann NA; Böhm V; Holtappels R; Reddehase MJ
    Virus Res; 2011 May; 157(2):161-74. PubMed ID: 20933556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspects of human cytomegalovirus latency and reactivation.
    Reeves M; Sinclair J
    Curr Top Microbiol Immunol; 2008; 325():297-313. PubMed ID: 18637513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCMV Antivirals and Strategies to Target the Latent Reservoir.
    Perera MR; Wills MR; Sinclair JH
    Viruses; 2021 May; 13(5):. PubMed ID: 34062863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing.
    Shnayder M; Nachshon A; Krishna B; Poole E; Boshkov A; Binyamin A; Maza I; Sinclair J; Schwartz M; Stern-Ginossar N
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in Model Systems for Human Cytomegalovirus Latency and Reactivation.
    Crawford LB; Diggins NL; Caposio P; Hancock MH
    mBio; 2022 Feb; 13(1):e0172421. PubMed ID: 35012351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency.
    Sabbaghian M; Gheitasi H; Fadaee M; Javadi Henafard H; Tavakoli A; Shekarchi AA; Poortahmasebi V
    Arch Virol; 2024 Jul; 169(8):157. PubMed ID: 38969819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis.
    Landais I; Nelson JA
    Curr Opin Virol; 2013 Aug; 3(4):408-15. PubMed ID: 23816389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
    Wills MR; Poole E; Lau B; Krishna B; Sinclair JH
    Cell Mol Immunol; 2015 Mar; 12(2):128-38. PubMed ID: 25132454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro.
    Arcangeletti MC; Vasile Simone R; Rodighiero I; De Conto F; Medici MC; Maccari C; Chezzi C; Calderaro A
    Virol J; 2016 Oct; 13(1):179. PubMed ID: 27770817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latency and reactivation of human cytomegalovirus.
    Sinclair J; Sissons P
    J Gen Virol; 2006 Jul; 87(Pt 7):1763-1779. PubMed ID: 16760381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. iTRAQ-Based Proteomics Analysis of Human Cytomegalovirus Latency and Reactivation in T98G Cells.
    Cheng S; Zhao F; Wen L; Yang B; Wang XZ; Huang SN; Jiang X; Zeng WB; Sun JY; Zhang FK; Shen HJ; Fortunato E; Luo MH; Cheng H
    J Virol; 2022 Jan; 96(2):e0147621. PubMed ID: 34730396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Latency and reactivation of HCMV].
    Eizuru Y
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():435-9. PubMed ID: 16615510
    [No Abstract]   [Full Text] [Related]  

  • 36. Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.
    Humby MS; O'Connor CM
    J Virol; 2015 Dec; 90(6):2959-70. PubMed ID: 26719258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.
    Gredmark-Russ S; Söderberg-Nauclér C
    Virulence; 2012 Nov; 3(7):621-34. PubMed ID: 23076329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic long-term culture (hLTC) for human cytomegalovirus latency and reactivation.
    Umashankar M; Goodrum F
    Methods Mol Biol; 2014; 1119():99-112. PubMed ID: 24639220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.
    Vancíková Z; Dvorák P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):179-87. PubMed ID: 12476798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Cytomegalovirus Latency: Approaching the Gordian Knot.
    Goodrum F
    Annu Rev Virol; 2016 Sep; 3(1):333-357. PubMed ID: 27501258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.